Dr. Aleksandar Rajkovic's lab at UCSF focuses on improving access to genomic healthcare, especially for underserved communities. They are implementing an innovative electronic consultation network called WestGEN, which connects healthcare providers with genetic specialists. This project not only enhances provider training in genomics but also explores the use of artificial intelligence to streamline these consultations, ultimately aiming to improve patient outcomes and health equity.

Dr. David Raleigh's lab at UCSF focuses on understanding and treating meningiomas, a type of brain tumor. The lab studies the genetic mechanisms that cause these tumors and aims to develop better treatments using innovative models. By using human samples and advanced techniques like organoids and CRISPR, they hope to improve outcomes for patients with meningiomas.

Dr. Jeroen Roose's lab at UCSF focuses on understanding how T cell receptors (TCR) signal within the immune system. They study the unique mechanisms by which T cells can differentiate between self and non-self, ensuring appropriate immune responses. The lab employs a range of techniques from structural biology to computational biology to explore how TCR signaling pathways are organized and regulated.

Dr. Howard J. Rosen's lab at UCSF focuses on improving the diagnosis of dementia within primary care settings, particularly for underserved communities. His research aims to develop effective tools that allow primary care providers to quickly and accurately identify cognitive impairments related to Alzheimer’s disease and other neurodegenerative disorders. By integrating clinical assessments with blood biomarkers and utilizing pre-visit questionnaires, the lab strives to enhance early diagnosis and support for patients and families.

Dr. Radojka Savic's lab at UCSF focuses on improving tuberculosis (TB) treatment by developing new drug regimens and diagnostics. The lab aims to enhance the accuracy of TB diagnosis through innovative blood tests that measure cell-free RNA, and to optimize treatment strategies using advanced modeling and animal studies. By collaborating with a multidisciplinary team, they seek to tackle the pressing global health challenge of TB, aiming for shorter and more effective treatment options.

Dr. Kevin Bender's lab at UCSF focuses on understanding and developing therapies for autism spectrum disorder (ASD) by investigating the role of the SCN2A gene. This gene, which affects neuronal sodium channels, is linked to various sensorimotor and behavioral deficits in mice modeled for ASD. The lab employs advanced CRISPR technology to potentially correct these deficiencies and improve cellular and behavioral functions in these models, paving the way for new treatments for severe forms of autism.

Dr. Ying-Hui Fu's lab at UCSF focuses on understanding how sleep quality and efficiency are regulated by the brain and nervous system. The lab studies individuals with genetic traits for natural short sleep, identifying specific genes that may lead to better sleep efficiency without negative health impacts. Using mouse models, the research explores the protective effects of quality sleep against neurodegenerative diseases, aiming to uncover mechanisms that could promote healthier aging and cognitive function.

Samira Soleimanpour's lab at the University of California, San Francisco focuses on researching school-based health centers (SBHCs) to understand which models are most effective in providing healthcare to youth, particularly in underserved communities. They aim to reduce disparities in health and academic outcomes by identifying best practices and barriers in SBHC operations. This lab's work is crucial for informing policies that can enhance access to health services for marginalized youth populations.

Dr. Matthew D Stachler's lab at UCSF focuses on understanding how Barrett's esophagus, a condition that can lead to esophageal cancer, progresses and how at-risk patients can be identified. The team develops and validates a combination of genomic and methylation biomarkers to enhance risk stratification for patients. Through this research, they aim to improve early detection and treatment of esophageal adenocarcinoma, which is often aggressive and difficult to manage.

Dr. James Solomon Fraser's lab at UCSF focuses on understanding the diverse structural forms that proteins can take, especially how these forms change in response to drugs or mutations. They develop advanced methods to visualize and manipulate these structures, aiming to improve drug design and create new treatments to fight antibiotic resistance. The lab combines experimental techniques in crystallography and cryo-electron microscopy with computational modeling to enhance our understanding of protein dynamics.

Dr. James A. Wells' lab focuses on understanding the proteins on the surface of cells, known as the surfaceome. These proteins are crucial for how cells communicate and respond to their environment. By developing innovative technologies, his team aims to analyze small populations of cells at high resolution, particularly in the context of cancer and neurodegenerative diseases. Their goal is to identify new biomarkers and drug targets, as well as to create specific antibodies that can better modulate cell functions.

Dr. Wendell Lim's lab at UCSF focuses on engineering immune cells to improve their ability to infiltrate and effectively treat solid tumors that typically repel immune responses. By developing synthetic circuits that enhance T cell trafficking towards these tumors, the team aims to increase the effectiveness of CAR T cell therapies, particularly against immune-excluded tumors like pancreatic cancer. This innovative approach to immunotherapy has the potential to revolutionize cancer treatment by making even hard-to-treat tumors vulnerable to immune attack.

Dr. Arun P. Wiita's lab at UCSF focuses on developing innovative therapies for acute myeloid leukemia (AML), a challenging blood cancer. Their research combines proteomics and immunotherapy techniques to identify and exploit unique surface proteins on cancer cells, aiming to create targeted treatments that are both effective and less toxic than existing options. The lab's recent work on radioimmunotherapy is poised to significantly improve patient outcomes in AML.

Dr. Angela Marie Phillips' lab at UCSF focuses on how antibodies evolve and adapt to combat the SARS-CoV-2 virus. The research explores the physical properties of antibodies and how these influence their effectiveness in attaching to diverse viral variants. By understanding these mechanisms, the lab aims to pave the way for designing better antibodies that can protect against current and future viruses.

Dr. Julie Beth Sneddon's lab at UCSF focuses on understanding how human pancreatic cells develop, specifically the beta cells that produce insulin. By studying the unique aspects of human cell development, especially through new techniques like single-cell multi-omics, the lab aims to enhance methods for creating these insulin-producing cells from stem cells. This research is vital for developing effective treatments for diabetes, a disease that affects millions worldwide.

Dr. Boon Lead Tee's lab at UCSF focuses on understanding how bilingualism impacts cognitive health, particularly in relation to Alzheimer's disease and related dementias. By studying diverse populations across multiple cultures and languages, the lab aims to uncover the ways bilingual experiences may contribute to cognitive resilience and longevity. This interdisciplinary approach combines neuroimaging, behavioral assessments, and social factors to better understand the complex relationships between language, cognition, and health.

Dr. Arnold Kriegstein's research lab focuses on understanding how the human brain develops and how its complexity relates to neurodevelopmental diseases like autism and schizophrenia. The lab uses innovative technologies to study both human tissue and stem cells to unravel the diversity of neural cells and their roles in brain function. By creating detailed brain atlases of both humans and non-human primates, the lab aims to uncover the fundamental processes of brain development and evolutionary distinctions, ultimately improving therapeutic strategies for brain-related disorders.

Dr. Kathryn A. Phillips' lab focuses on understanding how emerging genomic tests, like cell-free DNA tests and polygenic risk scores, can be integrated into healthcare policies and practices. The lab investigates payer coverage decisions to determine the economic value of these tests in both disease management and screening scenarios. They aim to ensure that advancements in genomic medicine are accessible and beneficial for all patients, addressing issues like equity and disparity in healthcare access.

Dr. Holly A. Ingraham's lab at UCSF focuses on understanding how the brain communicates with organs like the bladder and bones to maintain health, especially as we age. The team investigates neural circuits that influence urinary control and the relationship between the brain and bone health. Additionally, they explore the mechanisms behind abdominal pain related to digestive issues. This research aims to develop new strategies to improve health and quality of life for aging populations, particularly women.

Dr. Emily Lauren Goldberg's lab studies how aging affects immune cells in fat tissue and how these changes contribute to inflammation and related diseases in older adults. By understanding the mechanisms behind immune dysfunction, the lab aims to improve health outcomes and develop strategies to protect against age-related conditions. This research is particularly important as it focuses on the intersection of aging, inflammation, and metabolic health.